Table 2.

Median fluroescent Intensity of Vβ8.2, CD69, CD25, CD62L, and CD44 on CD4⁺ T Cells from Lymph Nodes after Injection of 2.4 mg of Soluble Peptide

Treatment		4 h		24 h		72 h		144 h
Vβ8.2
PBS		24.8		19.9		30.1		17.4
Ac1-11		24.1		19.3		26.4		17.3
Ac1-11[4A]		10.6		18.0		27.3		16.7
Ac1-11[4Y]		8.2		7.7		30.9		14.1
CD69
PBS		0.5		0.5		0.7		0.4
Ac1-11		31.6		15.2		1.0		0.5
Ac1-11[4A]		33.0		27.0		1.0		0.4
Ac1-11[4Y]		32.8		39.6		1.2		0.4
CD25
PBS		0.5		0.4		0.7		0.4
Ac1-11		10.1		4.6		1.9		0.7
Ac1-11[4A]		9.4		13.1		1.4		1.0
Ac1-11[4Y]		8.5		25.4		1.2		0.5
CD62L
PBS		24.0		16.5		35.0		23.6
Ac1-11		1.7		4.2		25.9		16.7
Ac1-11[4A]		1.2		3.5		29.4		19.2
Ac1-11[4Y]		1.4		2.7		58.4		17.9
CD44
PBS		2.2		2.5		6.9		3.4
Ac1-11		2.0		4.0		23.0		8.4
Ac1-11[4A]		2.2		5.9		29.3		9.3
Ac1-11[4Y]		2.1		4.8		16.3		8.4